Addressing Thalassaemia Management from Patients’ Perspectives: An International Collaborative Assessment
Medicina · 2024
DOI: 10.3390/medicina60040650 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medicina, 2024. Verfasst von Eleftheria C Economidou und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Larnaca General Hospital, 6043 Larnaca, Cyprus. Hauptthemen laut MEDLINE: Thalassemia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Thalassaemia International Federation.
Abstract (Originalsprache)
Background and Objectives: The effective management of chronic diseases, particularly hereditary and rare diseases and thalassaemia, is an important indicator of the quality of healthcare systems. We aimed to assess healthcare services in different countries for thalassaemia patients by using publicly available health indicators and by surveying thalassaemia patients and their caregivers. Materials and Methods: We reviewed official worldwide databases from the WHO, World Bank, and scientific resources, and we used a structured patient-tailored self-completed questionnaire to survey thalassaemia patients and their caregivers in 2023.
Results
A total of 2082 participants were surveyed (mean age, 27 years; males, 42%). About 1 in 4 respondents did not complete high-school education, while 24% had a bachelor’s degree. About a third of respondents were married and were in either full- or part-time employment. The vast majority (~80%) had initiated transfusion therapy between 1 and 4 years of age. Only 42% reported no delays in receiving blood transfusion, while 47% reported occasional delays and 8% serious delays. About half of patients reported being very satisfied (11%) or satisfied (38%) with the quality of services provided, while 1 in 3 patients reported being unsatisfied or very unsatisfied, and that their access to treatment was difficult or very difficult due to traveling expenses and the high cost of treatment.
Conclusions
Important improvements in the care of thalassaemia patients have been documented during the past few decades. Nevertheless, additional focus is required through national healthcare systems to effectively address the many unmet needs revealed by our recent survey, as well as to achieve satisfactory patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Larnaca General Hospital, 6043 Larnaca, Cyprus.
- Thalassaemia International Federation (TIF), 2007 Nicosia, Cyprus.
- Department of Public Health, Policy and Systems, University of Liverpool, Liverpool L69 3BX, UK.
- Healthcare Management Program, School of Economics and Management, Open University of Cyprus, 33 Giannou Kranidioti Ave., 2220 Nicosia, Cyprus.
- Department of Environmental Health, Environmental and Occupational Medicine and Epidemiology (EOME), Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.
ORCID-Profile: Eleftheria C Economidou, Michael Angastiniotis, Demetris Avraam, Elpidoforos S Soteriades
Förderung
- Thalassaemia International Federation
Zitieren
APA
Economidou, E. C., Angastiniotis, M., Avraam, D., Soteriades, E. S., & Eleftheriou, A. (2024). Addressing Thalassaemia Management from Patients’ Perspectives: An International Collaborative Assessment. Medicina. https://doi.org/10.3390/medicina60040650
Vancouver
Economidou EC, Angastiniotis M, Avraam D, Soteriades ES, Eleftheriou A. Addressing Thalassaemia Management from Patients’ Perspectives: An International Collaborative Assessment. Medicina. 2024. doi:10.3390/medicina60040650
BibTeX
@article{Economidou2024,
author = {Economidou, Eleftheria C and Angastiniotis, Michael and Avraam, Demetris and Soteriades, Elpidoforos S and Eleftheriou, Androulla},
title = {Addressing Thalassaemia Management from Patients’ Perspectives: An International Collaborative Assessment},
journal = {Medicina},
year = {2024},
doi = {10.3390/medicina60040650}
}
EUVIMED